Kohei Kashima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kohei Kashima has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Ito
Department of Pediatrics, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan
5 shared publications- Naoto Takahashi
Department of Pediatrics, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
4 shared publications - Yoshihiko Shitara
Department of Pediatrics, The University of Tokyo Hospital, Tokyo, 113-8655, Japan
4 shared publications - Goh Kimoto
Department of Pediatrics, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
3 shared publications - Eiichiro Watanabe
Department of General-Pediatric Hepatobiliary Pancreatic Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
2 shared publications - Eiryo Kawakami
Chiba University
2 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Elsevier in Pediatrics & Neonatology
Urinary prostaglandin E major urinary metabolite in neonates: Gestational age at birth-dependent dynamics and clinical implications
- 30 May 2026
- Published by Elsevier in Pediatrics & Neonatology
Open AccessUrinary prostaglandin E major urinary metabolite in neonates: Gestational age at birth-dependent dynamics and clinical implications
- 1 January 2026
- Published by Wiley in Congenital Anomalies
- Vol. 66 (1) , e70077
Severe Unilateral Hand Reduction Defect With a Central Cleft in a Child With Megalencephaly‐Capillary Malformation Syndrome
- 1 January 2026
- Published by Wiley in Congenital Anomalies
- Vol. 66 (1) , e70077
Severe Unilateral Hand Reduction Defect With a Central Cleft in a Child With Megalencephaly‐Capillary Malformation Syndrome
- Open Access
- 25 October 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 67 (3) , 248-253
Factors associated with extrauterine growth restriction in very-low-birth-weight infants: A retrospective study in Japan
- 25 October 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 67 (3) , 248-253
Open AccessFactors associated with extrauterine growth restriction in very-low-birth-weight infants: A retrospective study in Japan
- Open Access
- 25 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Author Correction: Host-derived protein profiles of human neonatal meconium across gestational ages
- 25 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Open AccessAuthor Correction: Host-derived protein profiles of human neonatal meconium across gestational ages
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e15892
Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study
Background: We aimed to reveal the transmission rate of coronavirus disease 2019 (COVID‐19) and clinical features of congenital and neonatal COVID‐19 and to disclose the efficacy of maternally transferred antibodies by maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Methods: This multicenter, prospective observational study included a comprehensive testing protocol with appropriate precautions. Mothers and infants were enrolled and classified into an active infection group (mothers with COVID‐19 at delivery), a postinfection group (mothers recovered from COVID‐19 during pregnancy), and a vaccination group (mothers vaccinated during pregnancy). Specimen collections, polymerase chain reaction assays, anti‐SARS‐CoV‐2 antibody measurements, and clinical examinations were conducted for 6 months from delivery. Results: Sixty‐nine mothers and 70 infants were enrolled. SARS‐CoV‐2 was detected in the placenta in 22% of the active infection group and in 21% of the postinfection group. Neither SARS‐CoV‐2 nor SARS‐CoV‐2‐specific IgM was detected in infants. No anomalies, functional disorders, or developmental problems were observed in infants for 6 months. Compared with the postinfection group, there was a significant increase in maternally transferred antibody titers in the vaccination group according to the number of vaccinations, which was maintained for longer than the first month of life. Conclusions: Vertical transmission of COVID‐19 was not observed despite a comprehensive testing protocol. SARS‐CoV‐2 was detected more often in the placenta, which appeared to prevent vertical transmission. Maternal vaccination increased maternally transferred antibody titers in infants and was considered immunologically efficient. Vaccination during pregnancy is considered important for preventing congenital, neonatal, and infantile COVID‐19.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e15892
Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study
Background: We aimed to reveal the transmission rate of coronavirus disease 2019 (COVID‐19) and clinical features of congenital and neonatal COVID‐19 and to disclose the efficacy of maternally transferred antibodies by maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Methods: This multicenter, prospective observational study included a comprehensive testing protocol with appropriate precautions. Mothers and infants were enrolled and classified into an active infection group (mothers with COVID‐19 at delivery), a postinfection group (mothers recovered from COVID‐19 during pregnancy), and a vaccination group (mothers vaccinated during pregnancy). Specimen collections, polymerase chain reaction assays, anti‐SARS‐CoV‐2 antibody measurements, and clinical examinations were conducted for 6 months from delivery. Results: Sixty‐nine mothers and 70 infants were enrolled. SARS‐CoV‐2 was detected in the placenta in 22% of the active infection group and in 21% of the postinfection group. Neither SARS‐CoV‐2 nor SARS‐CoV‐2‐specific IgM was detected in infants. No anomalies, functional disorders, or developmental problems were observed in infants for 6 months. Compared with the postinfection group, there was a significant increase in maternally transferred antibody titers in the vaccination group according to the number of vaccinations, which was maintained for longer than the first month of life. Conclusions: Vertical transmission of COVID‐19 was not observed despite a comprehensive testing protocol. SARS‐CoV‐2 was detected more often in the placenta, which appeared to prevent vertical transmission. Maternal vaccination increased maternally transferred antibody titers in infants and was considered immunologically efficient. Vaccination during pregnancy is considered important for preventing congenital, neonatal, and infantile COVID‐19.
- Open Access
- 17 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Host-derived protein profiles of human neonatal meconium across gestational ages
Meconium, a non-invasive biomaterial reflecting prenatal substance accumulation, could provide valuable insights into neonatal health. However, the comprehensive protein profile of meconium across gestational ages remains unclear. Here, we conducted an extensive proteomic analysis of first meconium from 259 newborns across varied gestational ages to delineate protein composition and elucidate its relevance to neonatal diseases. The first meconium samples were collected, with the majority obtained before feeding, and the mean time for the first meconium passage from the anus was 11.9 ± 9.47 h. Our analysis revealed 5370 host-derived meconium proteins, which varied depending on sex and gestational age. Specifically, meconium from preterm infants exhibited elevated concentrations of proteins associated with the extracellular matrix. Additionally, the protein profiles of meconium also exhibited unique variations depending on both specific diseases, including gastrointestinal diseases, congenital heart diseases, and maternal conditions. Furthermore, we developed a machine learning model to predict gestational ages using meconium proteins. Our model suggests that newborns with gastrointestinal diseases and congenital heart diseases may have immature gastrointestinal systems. These findings highlight the intricate relationship between clinical parameters and meconium protein composition, offering potential for a novel approach to assess neonatal gastrointestinal health.
- 17 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Open AccessHost-derived protein profiles of human neonatal meconium across gestational ages
Meconium, a non-invasive biomaterial reflecting prenatal substance accumulation, could provide valuable insights into neonatal health. However, the comprehensive protein profile of meconium across gestational ages remains unclear. Here, we conducted an extensive proteomic analysis of first meconium from 259 newborns across varied gestational ages to delineate protein composition and elucidate its relevance to neonatal diseases. The first meconium samples were collected, with the majority obtained before feeding, and the mean time for the first meconium passage from the anus was 11.9 ± 9.47 h. Our analysis revealed 5370 host-derived meconium proteins, which varied depending on sex and gestational age. Specifically, meconium from preterm infants exhibited elevated concentrations of proteins associated with the extracellular matrix. Additionally, the protein profiles of meconium also exhibited unique variations depending on both specific diseases, including gastrointestinal diseases, congenital heart diseases, and maternal conditions. Furthermore, we developed a machine learning model to predict gestational ages using meconium proteins. Our model suggests that newborns with gastrointestinal diseases and congenital heart diseases may have immature gastrointestinal systems. These findings highlight the intricate relationship between clinical parameters and meconium protein composition, offering potential for a novel approach to assess neonatal gastrointestinal health.
- Open Access
- 23 August 2023
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 65 (2) , 117-122
Treatments and outcomes of neonatal disseminated intravascular coagulation with and without neonatal asphyxia: A retrospective study using nationwide data in Japan
- 23 August 2023
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 65 (2) , 117-122
Open AccessTreatments and outcomes of neonatal disseminated intravascular coagulation with and without neonatal asphyxia: A retrospective study using nationwide data in Japan
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15642
Mucopolysaccharidosis II with neonatal respiratory distress syndrome and bronchopulmonary dysplasia
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15642
Mucopolysaccharidosis II with neonatal respiratory distress syndrome and bronchopulmonary dysplasia